UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 19, 2017

 

 

 

MONSTER DIGITAL, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-37797   27-3948465

(State or Other Jurisdiction

of Incorporation)  

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)  

 

     

2655 Park Center Drive, Unit C

Simi Valley, California 93065

  93065
(Address of Principal Executive Office)   (Zip Code)

 

 

Registrant’s telephone number, including area code: (805) 955-4190

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

  

Item 7.01 Regulation FD Disclosure.

 

On June 19, 2017, the Company issued a press release announcing that it has entered into a non-binding letter of intent which contemplates a proposed reverse merger with Innovate Biopharmaceuticals, Inc.

 

The press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information in this item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of Section 18, nor shall it be deemed incorporated by reference in any of the Company’s filings under the Securities Act of 1933, as amended or the Exchange Act, except to the extent, if any, expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

See the Exhibit Index set forth below for a list of exhibits included with this Form 8-K.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MONSTER DIGITAL, INC.  
     
  /s/ David Olert  
Date: June 20, 2017 David Olert  
  Chief Financial Officer  

 

 

 

 

EXHIBIT INDEX

 

     

Exhibit
No.

 

Description

   
99.1   Press Release of Monster Digital, Inc. dated June 19, 2017.

 

 

Innovate Biopharmaceutic... (NASDAQ:INNT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Innovate Biopharmaceutic... Charts.
Innovate Biopharmaceutic... (NASDAQ:INNT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Innovate Biopharmaceutic... Charts.